Facilities and Equipment is a very broad track intended to challenge those involved in the delivery of pharmaceutical facilities used to support the development, manufacturing, testing, and storage of pharmaceutical industry products meeting quality standards, employing efficient design, project delivery strategies, and adopting sustainable approaches to meet environmental expectations. The 2018 ISPE Annual Meeting & Expo Facilities Equipment Track will include industry owners, industry supplier experts, and innovators ready to share best practices and new approaches to advance efficiencies in the pharmaceutical manufacturing sector.
This year’s topics will address those areas that are currently challenging those who specify, design, and build our manufacturing plants including:
Facilities and Equipment Track session leaders and speakers have put together a program of case studies, industry surveys, practical experience, and forward-thinking strategies. Sessions include:
I look forward to meeting you in Philadelphia this November at the 2018 ISPE Annual Meeting & Expo – come join us as we examine ways to achieve efficiencies in manufacturing.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...